An obscure South Carolina company may be in line for millions of dollars in U.S. government funding to produce atreatment after a former Republican senator with a financial stake in the business lobbied senior U.S. government officials, the Associated Press reports.
Plasma Technologies LLC, has received seed money to test a possible COVID-19-fighting blood plasma technology. But as much as $65 million more could be on the way, a windfall for the company that operates out of the founder’s luxury condo, according to internal government records and other documents obtained by the Associated Press.
The story of how a tiny business that exists only on paper has managed to snare so much top-level attention is emblematic of theto the coronavirus pandemic.
And it’s another in a series of contracts awarded despite concerns over their proposals voiced by government scientists. The others include a